Literature DB >> 27551049

DUSP1 Maintains IRF1 and Leads to Increased Expression of IRF1-dependent Genes: A MECHANISM PROMOTING GLUCOCORTICOID INSENSITIVITY.

Suharsh Shah1, Elizabeth M King1, Mahmoud M Mostafa1, Mohammed O Altonsy1,2, Robert Newton3.   

Abstract

Although the mitogen-activated protein kinase (MAPK) phosphatase, DUSP1, mediates dexamethasone-induced repression of MAPKs, 14 of 46 interleukin-1β (IL1B)-induced mRNAs were significantly enhanced by DUSP1 overexpression in pulmonary A549 cells. These include the interferon regulatory factor, IRF1, and the chemokine, CXCL10. Of these, DUSP1-enhanced mRNAs, 10 including CXCL10, were IRF1-dependent. MAPK inhibitors and DUSP1 overexpression prolonged IRF1 expression by elevating transcription and increasing IRF1 mRNA and protein stability. Conversely, DUSP1 silencing increased IL1B-induced MAPK phosphorylation while significantly reducing IRF1 protein expression at 4 h. This confirms a regulatory network whereby DUSP1 switches off MAPKs to maintain IRF1 expression. There was no repression of IRF1 expression by dexamethasone in primary human bronchial epithelial cells, and in A549 cells IL1B-induced IRF1 protein was only modestly and transiently repressed. Although dexamethasone did not repress IL1B-induced IRF1 protein expression at 4-6 h, silencing of IL1B plus dexamethasone-induced DUSP1 significantly reduced IRF1 expression. IL1B-induced expression of CXCL10 was largely insensitive to dexamethasone, whereas other DUSP1-enhanced, IRF1-dependent mRNAs showed various degrees of repression. With IL1B plus dexamethasone, CXCL10 expression was also IRF1-dependent, and expression was reduced by DUSP1 silencing. Thus, IL1B plus dexamethasone-induced DUSP1 maintains expression of IRF1 and the IRF1-dependent gene, CXCL10. This is supported by chromatin immunoprecipitation showing IRF1 recruitment to be essentially unaffected by dexamethasone at the CXCL10 promoter or at the promoters of more highly repressed IRF1-dependent genes. Since IRF1-dependent genes, such as CXCL10, are central to host defense, these data may help explain the reduced effectiveness of glucocorticoids during asthma exacerbations.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CXCL10; DUSP1; IRF1; MKP-1; glucocorticoid; glucocorticoid resistance; inflammation; innate immunity; interferon regulatory factor (IRF); mitogen-activated protein kinase (MAPK)

Mesh:

Substances:

Year:  2016        PMID: 27551049      PMCID: PMC5076847          DOI: 10.1074/jbc.M116.728964

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

Review 1.  The innate immune response of the respiratory epithelium.

Authors:  G Diamond; D Legarda; L K Ryan
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

Review 2.  IRF family of transcription factors as regulators of host defense.

Authors:  T Taniguchi; K Ogasawara; A Takaoka; N Tanaka
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

4.  A constitutive active MEK --> ERK pathway negatively regulates NF-kappa B-dependent gene expression by modulating TATA-binding protein phosphorylation.

Authors:  A B Carter; G W Hunninghake
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

5.  The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.

Authors:  R Newton; L Cambridge; L A Hart; D A Stevens; M A Lindsay; P J Barnes
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Neutrophilic inflammation in severe persistent asthma.

Authors:  A Jatakanon; C Uasuf; W Maziak; S Lim; K F Chung; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

7.  Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability.

Authors:  K Nakagawa; H Yokosawa
Journal:  Eur J Biochem       Date:  2000-03

8.  Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras.

Authors:  X Zhou; V M Richon; A H Wang; X J Yang; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

9.  The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP).

Authors:  A B Carter; K L Knudtson; M M Monick; G W Hunninghake
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

10.  Interleukin-1beta induction of the chemokine RANTES promoter in the human astrocytoma line CH235 requires both constitutive and inducible transcription factors.

Authors:  N G Miyamoto; P S Medberry; J Hesselgesser; S Boehlk; P J Nelson; A M Krensky; H D Perez
Journal:  J Neuroimmunol       Date:  2000-06-01       Impact factor: 3.478

View more
  9 in total

Review 1.  Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance.

Authors:  Robert Newton; Suharsh Shah; Mohammed O Altonsy; Antony N Gerber
Journal:  J Biol Chem       Date:  2017-03-10       Impact factor: 5.157

2.  Glucocorticoid-driven transcriptomes in human airway epithelial cells: commonalities, differences and functional insight from cell lines and primary cells.

Authors:  Mahmoud M Mostafa; Christopher F Rider; Suharsh Shah; Suzanne L Traves; Paul M K Gordon; Anna Miller-Larsson; Richard Leigh; Robert Newton
Journal:  BMC Med Genomics       Date:  2019-01-31       Impact factor: 3.063

Review 3.  Role of Tristetraprolin in the Resolution of Inflammation.

Authors:  Peter Rappl; Bernhard Brüne; Tobias Schmid
Journal:  Biology (Basel)       Date:  2021-01-19

4.  Single-cell characterization of a model of poly I:C-stimulated peripheral blood mononuclear cells in severe asthma.

Authors:  Ailu Chen; Maria P Diaz-Soto; Miguel F Sanmamed; Taylor Adams; Jonas C Schupp; Amolika Gupta; Clemente Britto; Maor Sauler; Xiting Yan; Qing Liu; Gustavo Nino; Charles S Dela Cruz; Geoffrey L Chupp; Jose L Gomez
Journal:  Respir Res       Date:  2021-04-26

5.  Potentiation of long-acting β2-agonist and glucocorticoid responses in human airway epithelial cells by modulation of intracellular cAMP.

Authors:  Yechan Kim; Vincent Hou; Ryan D Huff; Jennifer A Aguiar; Spencer Revill; Nicholas Tiessen; Quynh Cao; Matthew S Miller; Mark D Inman; Kjetil Ask; Andrew C Doxey; Jeremy A Hirota
Journal:  Respir Res       Date:  2021-10-19

6.  Identification of Key Signaling Pathways and Genes in Eosinophilic Asthma and Neutrophilic Asthma by Weighted Gene Co-Expression Network Analysis.

Authors:  Gongqi Chen; Dian Chen; Yuchen Feng; Wenliang Wu; Jiali Gao; Chenli Chang; Shengchong Chen; Guohua Zhen
Journal:  Front Mol Biosci       Date:  2022-02-02

7.  IRF1 inhibits the proliferation and metastasis of colorectal cancer by suppressing the RAS-RAC1 pathway.

Authors:  Min Hong; Zuoyang Zhang; Qing Chen; Yanxia Lu; Jianming Zhang; Chun Lin; Fan Zhang; Wenjuan Zhang; Xiaomin Li; Wei Zhang; Xuenong Li
Journal:  Cancer Manag Res       Date:  2018-12-31       Impact factor: 3.989

8.  P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells.

Authors:  Simon Lea; Jian Li; Jonathan Plumb; Kate Gaffey; Sarah Mason; Rosie Gaskell; Chris Harbron; Dave Singh
Journal:  J Mol Med (Berl)       Date:  2020-01-23       Impact factor: 4.599

Review 9.  Pleiotropic Effects of Glucocorticoids on the Immune System in Circadian Rhythm and Stress.

Authors:  Akihiro Shimba; Aki Ejima; Koichi Ikuta
Journal:  Front Immunol       Date:  2021-10-08       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.